Pozelimab
- Commodity name： Pozelimab
Detailed description
- Product Description
-
Product Specifications
Product item number XC978995-100µg English name Pozelimab Chinese name Pazolizumab Antibody source Human Clone Type Monoclonal Physical State Liquid Concentration 1 mg/mL Subtype IgG4κ Expression system CHO-K1 stable cell line Purification method Affinity purified by Protein A Buffer solution 0.2 μm filtered in PBS, pH 7.4, 10% glycerol Purity ＞98% as determined by SDS-PAGE；＞98% as determined by SEC-HPLC Storage conditions
Aliquot and store at -20°C to -80°C,Avoid repeat freeze-thaw cycles.
Precautions
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Product Introduction
Pozelimab is a human IgG4κ mAb that targets complement factor 5 (C5) to help prevent diseases mediated by the complement pathway，Pozelimab targets complement factor C5, a protein involved in the complement cascade, which plays a key role in inflammation and immune responses.By inhibiting C5, Pozelimab prevents the formation of C5a (a pro-inflammatory molecule) and C5b-9 (the membrane attack complex), which can cause tissue damage in certain diseases.
Documentary materials
Keywords:
Reference drug | Anti-drug antibodies | Instrument | Reagent
Related products
Product Item Number: XC978996-100µg English Name: Mirikizumab Chinese Name: 米吉珠单抗
View DetailsProduct Item Number: XC978995-100µg English Name: Pozelimab Chinese Name: Pazelimumab
View DetailsWelcome to leave us a message or inquiry.
Subscription Information
Subscribe to receive updates from Xichang News.
Shanghai Constream biotechnology Co., Ltd
Phone:021-59255902
Address: Building 2, Floors 2–3, Lane 10688, Beiqing Road, Qingpu District, Shanghai
WeChat Official Account
Copyright © 2026 Shanghai Constream biotechnology Co., Ltd.